A Microfluidic Platform to design crosslinked Hyaluronic Acid Nanoparticles (cHANPs) for enhanced MRI

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Russo, Maria ^a,b   Bevilacqua, Paolo ^a,c   Netti, Paolo Antonio ^a,b   Torino, Enza ^a,b  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; GADOLINIUM PENTETATE; HYALURONIC ACID; NANOMATERIAL; NANOPARTICLE;

CHEMISTRY; MICROFLUIDICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES;

CONTRAST MEDIA; GADOLINIUM; GADOLINIUM DTPA; HYALURONIC ACID; MAGNETIC RESONANCE IMAGING; MICROFLUIDICS; NANOPARTICLES; NANOSTRUCTURES;

EID: 84999218006     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep37906     Document Type: Article

References (62)

1. Mansfield, P. Snapshot magnetic resonance imaging (nobel lecture). Angewandte Chemie-International Edition 43, 5456-5464, doi: 10.1002/anie.200460078 (2004).
2. Caravan, P., Ellison, J. J., McMurry, T. J. & Lauffer, R. B. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chemical Reviews 99, 2293-2352, doi: 10.1021/cr980440x (1999).
3. Rutt, B. K. & Lee, D. H. The impact of field strength on image quality in MRI. Jmri-Journal of Magnetic Resonance Imaging 6, 57-62, doi: 10.1002/jmri.1880060111 (1996).
4. Sethi, R. et al. Enhanced MRI relaxivity of Gd3+ -based contrast agents geometrically confined within porous nanoconstructs. Contrast Media & Molecular Imaging 7, 501-508, doi: 10.1002/cmmi.1480 (2012).
5. Xue, S. H., Qiao, J. J., Pu, F., Cameron, M. & Yang, J. J. Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology 5, 163-179, doi: 10.1002/wnan.1205 (2013).
6. Caravan, P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chemical Society Reviews 35, 512-523, doi: 10.1039/b510982p (2006).
7. Laurent, S., Elst, L. V. & Muller, R. N. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media & Molecular Imaging 1, 128-137, doi: 10.1002/cmmi.100 (2006).
8. Toth, T., Helm, L. & Merbach, A. E. Relaxivity of gadolinium(III) complexes: Theory and mechanism. Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging 45-119 (2001).
9. Penfield, J. G. & Reilly, R. F. Jr. What nephrologists need to know about gadolinium. Nature Clinical Practice Nephrology 3, 654-668, doi: 10.1038/ncpneph0660 (2007).
10. McDonald, R. J. et al. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology 275, 772-782, doi: 10.1148/radiol.15150025 (2015).
11. Cao, C.-Y., Shen, Y.-Y., Wang, J.-D., Li, L. & Liang, G.-L. Controlled intracellular self-assembly of gadolinium nanoparticles as smart molecular MR contrast agents. Scientific Reports 3, doi: 10.1038/srep01024 (2013).
12. Ahmad, M. W. et al. Potential dual imaging nanoparticle: Gd2O3 nanoparticle. Scientific Reports 5, doi: 10.1038/srep08549 (2015).
13. Moriggi, L. et al. Gold Nanoparticles Functionalized with Gadolinium Chelates as High-Relaxivity MRI Contrast Agents. Journal of the American Chemical Society 131, 10828-+, doi: 10.1021/ja904094t (2009).
14. Cheng, Z. L., Thorek, D. L. J. & Tsourkas, A. Gadolinium-Conjugated Dendrimer Nanoclusters as a Tumor-Targeted T-1 Magnetic Resonance Imaging Contrast Agent. Angewandte Chemie-International Edition 49, 346-350, doi: 10.1002/anie.200905133 (2010).
15. Huang, C. H., Nwe, K., Al Zaki, A., Brechbiel, M. W. & Tsourkas, A. Biodegradable Polydisulfide Dendrimer Nanoclusters as MRI Contrast Agents. Acs Nano 6, 9416-9424, doi: 10.1021/nn304160p (2012).
16. Chen, K. J. et al. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity. Biomaterials 32, 2160-2165, doi: 10.1016/j.biomaterials.2010.11.043 (2011).
17. Felton, C. et al. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron-and manganese-based magnetic nanoparticles. Drug Metabolism Reviews 46, 142-154 (2014).
18. Kim, T. et al. Mesoporous Silica-Coated Hollow Manganese Oxide Nanoparticles as Positive T-1 Contrast Agents for Labeling and MRI Tracking of Adipose-Derived Mesenchyrnal Stem Cells. Journal of the American Chemical Society 133, 2955-2961, doi: 10.1021/ja1084095 (2011).
19. Wen, S. H. et al. Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications. Biomaterials 34, 1570-1580, doi: 10.1016/j.biomaterials.2012.11.010 (2013).
20. Na, H. B., Song, I. C. & Hyeon, T. Inorganic Nanoparticles for MRI Contrast Agents. Advanced Materials 21, 2133-2148, doi: 10.1002/adma.200802366 (2009).
21. Ananta, J. S. et al. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T-1 contrast. Nature Nanotechnology 5, 815-821, doi: 10.1038/nnano.2010.203 (2010).
22. Sethi, R. et al. Enhanced MRI relaxivity of Gd3+ -based contrast agents geometrically confined within porous nanoconstructs. Contrast Media & Molecular Imaging 7, 501-508, doi: 10.1002/cmmi.1480 (2012).
23. Gizzatov, A. et al. Geometrical confinement of Gd(DOTA) molecules within mesoporous silicon nanoconstructs for MR imaging of cancer. Cancer Letters 352, 97-101, doi: 10.1016/j.canlet.2014.06.001 (2014).
24. Courant, T. et al. Hydrogels Incorporating GdDOTA: Towards Highly Efficient Dual T1/T2 MRI Contrast Agents. Angewandte Chemie-International Edition 51, 9119-9122, doi: 10.1002/anie.201203190 (2012).
25. Ponsiglione, A., Russo, M., Netti, P. & Torino, E. Impact of biopolymer matrices on relaxometric properties of contrast agents. Interface Focus 20160061, doi: http://dx.doi.org/10.1098/rsfs.2016.0061 (2016).
26. Mitragotri, S. & Lahann, J. Physical approaches to biomaterial design. Nature Materials 8, 15-23, doi: 10.1038/nmat2344 (2009).
27. Schubert, S., Delaney, J. T., Jr. & Schubert, U. S. Nanoprecipitation and nanoformulation of polymers: from history to powerful possibilities beyond poly(lactic acid). Soft Matter 7, 1581-1588, doi: 10.1039/c0sm00862a (2011).
28. Quintanar-Guerrero, D., Allemann, E., Doelker, E. & Fessi, H. Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique. Pharmaceutical Research 15, 1056-1062 (1998).
29. Mora-Huertas, C. E., Fessi, H. & Elaissari, A. Polymer-based nanocapsules for drug delivery. International Journal of Pharmaceutics 385, 113-142, doi: 10.1016/j.ijpharm.2009.10.018 (2010).
30. Knopp, E. A. & Cowper, S. E. Nephrogenic systemic fibrosis: Early recognition and treatment. Seminars in Dialysis 21, 123-128, doi: 10.1111/j.1525-139X.2007.00399.x (2008).
31. Lim, J. M. et al. Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study. Nanomedicine-Nanotechnology Biology and Medicine 10, 401-409, doi: 10.1016/j.nano.2013.08.003 (2014).
32. Lim, J.-M. et al. Ultra-High Throughput Synthesis of Nanoparticles with Homogeneous Size Distribution Using a Coaxial Turbulent Jet Mixer. Acs Nano 8, 6056-6065, doi: 10.1021/nn501371n (2014).
33. Lazarus, L. L., Yang, A. S. J., Chu, S., Brutchey, R. L. & Malmstadt, N. Flow-focused synthesis of monodisperse gold nanoparticles using ionic liquids on a microfluidic platform. Lab on a Chip 10, 3377-3379, doi: 10.1039/c0lc00297f (2010).
34. Conde, A. J. et al. Continuous flow generation of magnetoliposomes in a low-cost portable microfluidic platform. Lab on a Chip 14, 4506-4512, doi: 10.1039/c4lc00839a (2014).
35. Herranz-Blanco, B. et al. Microfluidic assembly of multistage porous silicon-lipid vesicles for controlled drug release. Lab on a Chip 14, 1083-1086, doi: 10.1039/c3lc51260f (2014).
36. Karnik, R. et al. Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Letters 8, 2906-2912, doi: 10.1021/nl801736q (2008).
37. Zhu, Z. Q., Si, T. & Xu, R. X. Microencapsulation of indocyanine green for potential applications in image-guided drug delivery. Lab on a Chip 15, 646-649, doi: 10.1039/c4lc01032a (2015).
38. Sah, E. & Sah, H. Recent Trends in Preparation of Poly(lactide-co-glycolide) Nanoparticles by Mixing Polymeric Organic Solution with Antisolvent. Journal of Nanomaterials. 22, doi: 10.1155/2015/794601 (2015).
39. Jahn, A. et al. Microfluidic Mixing and the Formation of Nanoscale Lipid Vesicles. Acs Nano 4, 2077-2087, doi: 10.1021/nn901676x (2010).
40. Hood, R. R. & DeVoe, D. L. High-Throughput Continuous Flow Production of Nanoscale Liposomes by Microfluidic Vertical Flow Focusing. Small 11, 5790-5799, doi: 10.1002/smll.201501345 (2015).
41. Lu, M. et al. Shape-Controlled Synthesis of Hybrid Nanomaterials via Three-Dimensional Hydrodynamic Focusing. Acs Nano 8, 10026-10034, doi: 10.1021/nn502549v (2014).
42. Kang, X. et al. Mass production of highly monodisperse polymeric nanoparticles by parallel flow focusing system. Microfluidics and Nanofluidics 15, 337-345, doi: 10.1007/s10404-013-1152-6 (2013).
43. Rhee, M. et al. Synthesis of Size-Tunable Polymeric Nanoparticles Enabled by 3D Hydrodynamic Flow Focusing in Single-Layer Microchannels. Advanced Materials 23, H79-H83, doi: 10.1002/adma.201004333 (2011).
44. Xu, Q. et al. Preparation of Monodisperse Biodegradable Polymer Microparticles Using a Microfluidic Flow-Focusing Device for Controlled Drug Delivery. Small 5, 1575-1581, doi: 10.1002/smll.200801855 (2009).
45. DeMello, J. & DeMello, A. Microscale reactors: nanoscale products. Lab on a Chip 4, 11N-15N, doi: 10.1039/b403638g (2004).
46. Min, K. I., Im, D. J., Lee, H. J. & Kim, D. P. Three-dimensional flash flow microreactor for scale-up production of monodisperse PEG-PLGA nanoparticles. Lab on a Chip 14, 3987-3992, doi: 10.1039/c4lc00700j (2014).
47. Carugo, D., Bottaro, E., Owen, J., Stride, E. & Nastruzzi, C. Liposome production by microfluidics: potential and limiting factors. Scientific Reports 6, doi: 10.1038/srep25876 (2016).
48. Valencia, P. M. et al. Single-Step Assembly of Homogenous Lipid - Polymeric and Lipid - Quantum Dot Nanoparticles Enabled by Microfluidic Rapid Mixing. Acs Nano 4, 1671-1679, doi: 10.1021/nn901433u (2010).
49. Capretto, L. et al. Mechanism of co-nanoprecipitation of organic actives and block copolymers in a microfluidic environment. Nanotechnology 23, 16, doi: 10.1088/0957-4484/23/37/375602 (2012).
50. Souza Bicudo, R. C. & Andrade Santana, M. H. Production of hyaluronic acid (HA) nanoparticles by a continuous process inside microchannels: Effects of non-solvents, organic phase flow rate, and HA concentration. Chemical Engineering Science 84, 134-141, doi: 10.1016/j.ces.2012.08.010 (2012).
51. Capretto, L., Carugo, D., Mazzitelli, S., Nastruzzi, C. & Zhang, X. Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications. Advanced Drug Delivery Reviews 65, 1496-1532, doi: 10.1016/j. addr.2013.08.002 (2013).
52. Oh, E. J. et al. Control of the molecular degradation of hyaluronic acid hydrogels for tissue augmentation. Journal of Biomedical Materials Research Part A 86A, 685-693, doi: 10.1002/ibm.a.31681 (2008).
53. Kozlowski, H., Brown, D. R. & Valensin, G. Metallochemistry of Neurodegeneration: Biological, Chemical and Genetic Aspects. Metallochemistry of Neurodegeneration: Biological, Chemical and Genetic Aspects 1-281, doi: 10.1039/9781847555311 (2006).
54. Strijkers, G. J., Mulder, W. J. M., van Tilborg, G. A. F. & Nicolay, K. MRI contrast agents: Current status and future perspectives. Anti-Cancer Agents in Medicinal Chemistry 7, 291-305, doi: 10.2174/187152007780618135 (2007).
55. Bicudo, R. C. S. & Santana, M. H. A. Production of hyaluronic acid (HA) nanoparticles by a continuous process inside microchannels: Effects of non-solvents, organic phase flow rate, and HA concentration. Chemical Engineering Science 84, 134-141, doi: 10.1016/j.ces.2012.08.010 (2012).
56. Weissmann, B. & Meyer, K. The structure of hyalobiuronic acid and of hyaluronic acid from umbilical Cord1, 2. Journal of the american chemical society 76, 1753-1757 (1954).
57. Gouin, S. & Winnik, F. M. Quantitative assays of the amount of diethylenetriaminepentaacetic acid conjugated to water-soluble polymers using isothermal titration calorimetry and colorimetry. Bioconjugate Chemistry 12, 372-377, doi: 10.1021/bc000109w (2001).
58. Joye, I. J. & McClements, D. J. Biopolymer-Based Delivery Systems: Challenges and Opportunities. Current Topics in Medicinal Chemistry 16, 1026-1039, doi: 10.2174/1568026615666150825143130 (2016).
59. Shimojo, A. A. M., Pires, A. M. B., Lichy, R. & Santana, M. H. A. The Performance of Crosslinking with Divinyl Sulfone as Controlled by the Interplay Between the Chemical Modification and Conformation of Hyaluronic Acid. Journal of the Brazilian Chemical Society 26, 506-512, doi: 10.5935/0103-5053.20150003 (2015).
60. Collins, M. N. & Birkinshaw, C. Investigation of the swelling behavior of crosslinked hyaluronic acid films and hydrogels produced using homogeneous reactions. Journal of Applied Polymer Science 109, 923-931, doi: 10.1002/app.27631 (2008).
61. Schante, C. E., Zuber, G., Herlin, C. & Vandamme, T. F. Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications. Carbohydrate Polymers 85, 469-489, doi: 10.1016/j.carbpol.2011.03.019 (2011).
62. Provencher, S. W. CONTIN: a general purpose constrained regularization program for inverting noisy linear algebraic and integral equations. Computer Physics Communications 27, 229-242 (1982).